Discover available B·R·A·H·M·S Biomarker Assays
Thermo Scientific B·R·A·H·M·S Biomarkers, with outstanding long-term lot-to-lot stability, provide the highest precision for the most reliable results in prenatal screening.1 With our biomarker portfolio, we are providing solutions for pre-eclampsia from the first to the third trimester.
B·R·A·H·M·S PAPP-A KRYPTOR
Intended uses
| Screening for pre-eclampsia in first trimester |
 |
US Only: Product is not FDA cleared in US.
Product specifications
| Sample volume | 50 µL |
| Sample type | Serum |
| Incubation time | 19 min |
| Linear direct measuring range | 0.010 to 6 IU/L |
| Upper measuring range with automatic dilution | up to 90 IU/L |
| Limit of detection | 0.0054 IU/L |
| Limit of quantification | 0.01 IU/L |
| Kit stability on board | 29 days |
| Calibrator | 1 point |
| Calibration stability | 15 days |
B·R·A·H·M·S PAPP-A KRYPTOR kit and accessories
| Article number | Description |
| 866075N | B·R·A·H·M·S PAPP-A KRYPTOR Kit, reagents for 75 determinations |
| 086691N | B·R·A·H·M·S PAPP-A KRYPTOR CAL Calibrator kit, 6 vials |
| 088192N | B·R·A·H·M·S GM KRYPTOR QC Control kit prenatal screening, 3 levels (2 vials per level) |
Not for sale in the US.
B·R·A·H·M·S PlGF plus KRYPTOR
Intended uses
| Screening for pre-eclampsia | Aid pre-eclampsia diagnosis | Aid pre-eclampsia prognosis | Aid pre-eclampsia rule in / rule out |
||
| First trimester | Second trimester | Third trimenter | From week 20 | ||
|
|
|
|
|
|
US only: PlGF is not approved for screening in the 1st trimester, nor as an aid for diagnosis or rule in/out.
Product specifications
| Sample volume | 70 µL |
| Sample type | Serum, EDTA plasma |
| Incubation time | 29 min |
| Linear direct measuring range | 7.7 to 7 000 pg/mL |
| Limit of detection | 4.91 pg/mL |
| Limit of quantification | 7.7 pg/mL |
| Kit stability on board | 29 days |
| Calibrator | 1 point |
| Calibration stability | 15 days |
B·R·A·H·M·S sFlt-1 KRYPTOR
Intended uses
| Screening for pre-eclampsia | Aid pre-eclampsia diagnosis | Aid pre-eclampsia prognosis | Aid pre-eclampsia rule in / rule out |
|
| Second trimester | Third trimenter | From week 20 | ||
|
|
|
|
|
US only: sFlt-1 is not cleared as an aid in diagnosis nor rule in/out.
Product specifications
| Sample volume | 8 µL |
| Sample type | Serum, EDTA plasma |
| Incubation time | 9 min |
| Linear direct measuring range | 39.5 to 90 000 pg/mL |
| Limit of detection | 28.5 pg/mL |
| Limit of quantification | 39.5 pg/mL |
| Kit stability on board | 29 days |
| Calibrator | 2 point |
| Calibration stability | 15 days |
References
1. Monthly UK NEQAS reports, February 2003 - December 2023.
Thermo Fisher Scientific products are distributed globally and their uses, applications, indications, claims and availability of products in each country depend on local regulatory marketing authorization status, please consult the Instructions For Use (IFU) available in your country.
© 2024 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. B·R·A·H·M·S is a registered trademark of B·R·A·H·M·S GmbH.
KRYPTOR and TRACE are trademarks of Cisbio Bioassays, licensed for use by B·R·A·H·M·S GmbH, a part of Thermo Fisher Scientific. Nobel Prize is a registered trademark of the Nobel Foundation.